Search    Show all

1 People found

filters applied:


1 / 1

EMBO Member

Patrick Mehlen

Cancer Research Center of Lyon (CRCL), Lyon | France

EMBO 2006

The dependence receptor notion

My group develops the dependence receptor paradigm. Such dependence receptor triggers cell death unless bound by its ligand, generating a cellular state of dependence on the presence of ligand. This feature constrains tumor progression and aggressive cancers may select to silence this death pathway to survive by upregulating the ligand. We have translated this with a first anti-ligand (netrin-1) antibody entering into phase I clinical trial.

Keywords: Dependence receptor / apoptosis / cancer / neuronal navigation / tumor suppressor gene

Subject area(s): Development | Differentiation & Death | Molecular Medicine